Jason A Amello's most recent trade in Tscan Therapeutics Inc was a trade of 270,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tscan Therapeutics Inc | Jason A. Amello | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 270,000 | 270,000 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Jason A. Amello | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 750,000 | 750,000 | - | - | Stock Option (Right to Buy) | |
| Acer Therapeutics Inc | Jason A. Amello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Acer Therapeutics Inc | Jason A. Amello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 18,500 | 18,500 | - | - | Stock Option (right to buy) | |
| Acer Therapeutics Inc | Jason A. Amello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) |